Cafeity Get the app

People

Telling people you're on a GLP-1, or not: scripts for work, family and friends

Starting a GLP-1 is a medical decision, and who hears about it is yours to decide. Some people tell everyone, some tell no one, and most land somewhere in between. Here is how to think it through, with scripts for the conversations that come up most — at work, at home, with friends, and with the people who comment anyway.

By the Cafeity teamUpdated 6 min read

The short answer

You don't have to tell anyone you're on a GLP-1. In the US, an employer generally may not ask all employees which prescription medicines they take, and must treat medical information you choose to share as a confidential record.1 If you do want to tell people, keep it short: say what you are comfortable sharing, what support you would like, and what you would rather not discuss. You are far from alone — in a November 2025 poll, 12% of US adults said they were currently taking a GLP-1.2

A man talking on a landline phone by a window, listening closely.
Who you tell, how much you say and when you say it are all your call, and you can change your mind later.Image: Cafeity.

Deciding whether to tell

There is no right answer, only the one that suits your life. A few questions help:

  • Who needs to know for practical reasons? People who share your meals, someone who would help if you felt unwell, a travelling companion if you carry your medicine (see travelling with a GLP-1).
  • Whose support would you like? Telling one or two people who will be kind is often worth more than telling everyone.
  • Who is likely to react badly? You don't owe them the information, or a debate about it.
  • What would you share? "I'm on a medicine that makes me full quickly" is a complete answer. The name, the reason and anything about your dose can stay private.

One group always needs to know: the clinicians who treat you. The semaglutide label asks patients to tell their healthcare providers before any planned surgery or procedure, because a slower-emptying stomach can complicate anaesthesia or deep sedation.3 That includes dentists and anyone giving sedation.

You are far from the only one

It can feel like a confession. It isn't. In KFF's November 2025 poll of 1,350 US adults, 12% said they were currently taking a GLP-1 drug and 18% said they had taken one at some point. About four in ten (37%) said a close friend or family member was using one.2

The same poll found that most users take these medicines for more than weight: 38% said they took them mainly for a chronic condition such as diabetes or heart disease, 32% for both a condition and weight loss, and 30% mainly to lose weight.2 Whatever your reason, it is a prescription between you and your clinician.

At work

You generally don't have to tell your employer. Under the Americans with Disabilities Act, an employer may ask disability-related questions of employees only when they are job-related and consistent with business necessity. The EEOC's guidance says that asking all employees about their prescription medicines generally does not meet that standard, with narrow exceptions for some public-safety jobs. Any medical information you do share, even voluntarily, must be kept as a confidential medical record.1 Rules differ outside the US.

If side effects affect your work — a rough morning after a dose, say — you can ask for an adjustment without naming the medicine. See working through nausea days.

Lines for the office.
WhenYou could say
A colleague asks about your weight"Thanks, I'm feeling good." Then move on to the meeting.
Someone asks directly if you're "on one of those""I keep health stuff private at work, but thanks for asking."
The team orders lunch"I'll grab something small. I'm not very hungry today."
Your manager notices you're off-colour"I'm dealing with a health thing that's settling down. Could I take the 9 am call from home tomorrow?"

With family

Families are where food and bodies get discussed most freely, so it helps to decide in advance how much you want to say. If you tell them, say what you would like from them as well as what you are doing:

  • "My doctor and I have started me on a medicine that makes me full quickly. I'm going to eat smaller portions — please don't take it personally."
  • "I'm happy to talk about it, but not at the dinner table."
  • "The most helpful thing would be not commenting on my plate."

If someone calls it "the easy way out", you can point out — or simply know — that a 2020 international consensus statement on weight stigma concluded that body weight is not entirely under voluntary control, and that biological, genetic and environmental factors play a critical part.4 Medicine for a medical condition is not cheating.

With friends

Friends mostly notice the practical changes: you eat less when you go out, you drink less, you leave food on the plate. A light, honest line usually ends it: "I'm on a medicine that fills me up fast, so I'll share a starter." If friends ask how it works or whether it would suit them, describe your own experience and point them to their own clinician — what suits one person's health may not suit another's.

For meals out, see eating out on a GLP-1; for nights out, alcohol on a GLP-1.

When people comment anyway

Short, repeatable, and none of them invite a follow-up.
CommentYou could say
"Isn't that the easy way out?""It's a prescription from my doctor, like any other."
"Aren't those dangerous?""My doctor and I keep an eye on it. Thanks for caring."
"You look ill.""I feel well, thanks." If it keeps happening, "Please don't comment on my body."
"What dose are you on?""I'd rather keep my prescription private."
"Can you get me some?""You'd need to talk to your own doctor — it's prescribed for one person."

Weight stigma is common and can cause physical and psychological harm, according to the 2020 consensus statement, so it is reasonable to set limits on these conversations.4

Telling people online

Posting about treatment can bring support, and it is permanent. Before you share, think about who can see it now and later — employers, relatives, future partners. Communities for people on GLP-1 medicines can be useful for experiences and tips; take any advice about doses or switching medicines back to your prescriber rather than acting on it.

Keeping a record of it

Cafeity never sells your health data or uses it for advertising or tracking, and a Visit Summary only goes to someone when you export it and choose who gets it.

Cafeity Visit Summary set-up: a period picker (4 weeks, 3 months, 6 months, custom) and switches for medication and doses, weight trend, body measurements, symptoms, protein and energy, activity and sleep, and notes tagged for the prescriber.
You choose what goes in a Visit Summary.
Cafeity Today screen: day 1 of 7 since the last dose with the estimated level at 97% of peak, fibre 21 of 25 g, protein 110 of 100 g, steps, water 850 ml of 2.4 L, the next logged dose and the weight trend.
Your day at a glance.

Screenshots: Cafeity for iPhone, version 1.1.

Download Cafeity on the App Store

Common questions

Do I have to tell my employer I'm on a GLP-1?
Generally no. Under the ADA, employers may ask disability-related questions only when they are job-related and consistent with business necessity, and must keep any medical information you share confidential.1
Can my employer ask what medicines I take?
The EEOC says asking all employees about prescription medicines is generally not job-related and consistent with business necessity, with limited exceptions for some public-safety roles.1
How common is it to be on a GLP-1?
In KFF's November 2025 poll, 12% of US adults said they were currently taking a GLP-1 drug and 18% said they had ever taken one.2
What do I say when someone calls it the easy way out?
"It's a prescription from my doctor, like any other." A 2020 consensus statement concluded that body weight is not entirely under voluntary control.4
Should I tell my dentist or surgeon?
Yes. The label asks patients to tell their healthcare providers before any planned surgery or procedure, because slower stomach emptying can complicate anaesthesia or deep sedation.3

Sources

  1. Enforcement guidance on disability-related inquiries and medical examinations of employees under the Americans with Disabilities Act US Equal Employment Opportunity Commission
  2. Poll: 1 in 8 adults say they are currently taking a GLP-1 drug for weight loss, diabetes or another condition, even as half say the drugs are difficult to afford KFF Health Tracking Poll (fieldwork 27 October–2 November 2025, 1,350 US adults), 14 November 2025
  3. Semaglutide injection and tablets for weight management — US prescribing information DailyMed, US National Library of Medicine, version published 30 June 2026
  4. Joint international consensus statement for ending stigma of obesity Rubino F et al. Nature Medicine 2020;26:485–497

Written by the Cafeity team from the sources listed here. Figures from prescribing information are quoted as the label states them; trial results are averages from those trials, not predictions for any one person. This page has not yet been reviewed by a clinician — see the editorial policy for how pages are researched and corrected.